John Danziger, Jeffrey H William, Daniel J Scott, Joon Lee, Li-wei Lehman, Roger G Mark, Michael D Howell, Leo A Celi, Kenneth J Mukamal
Although case reports link proton-pump inhibitor (PPI) use and hypomagnesemia, no large-scale studies have been conducted. Here we examined the serum magnesium concentration and the likelihood of hypomagnesemia (<1.6 mg/dl) with a history of PPI or histamine-2 receptor antagonist used to reduce gastric acid, or use of neither among 11,490 consecutive adult admissions to an intensive care unit of a tertiary medical center. Of these, 2632 patients reported PPI use prior to admission, while 657 patients were using a histamine-2 receptor antagonist...
April 2013: Kidney International